These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 9076930

  • 1. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
    Muhm M, Claeys L, Huk I, Koppensteiner R, Kyrle PA, Minar E, Stümpflen A, Ehringer H, Polterauer P.
    Wien Klin Wochenschr; 1997 Feb 28; 109(4):128-31. PubMed ID: 9076930
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
    Ortel TL, Gockerman JP, Califf RM, McCann RL, O'Connor CM, Metzler DM, Greenberg CS.
    Thromb Haemost; 1992 Mar 02; 67(3):292-6. PubMed ID: 1379384
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The management of heparin-induced thrombocytopenia.
    Keeling D, Davidson S, Watson H, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Br J Haematol; 2006 May 02; 133(3):259-69. PubMed ID: 16643427
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures.
    Kodityal S, Manhas AH, Udden M, Rice L.
    Eur J Haematol; 2003 Aug 02; 71(2):109-13. PubMed ID: 12890149
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Heparin-induced thrombocytopenia: cross-reactivity between standard heparin, low molecular weight heparin, dalteparin (Fragmin) and heparinoid, danaparoid (Orgaran).
    Ramakrishna R, Manoharan A, Kwan YL, Kyle PW.
    Br J Haematol; 1995 Nov 02; 91(3):736-8. PubMed ID: 8555084
    [Abstract] [Full Text] [Related]

  • 16. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
    Darling K, Jaumotte C, Saussoy P, Zech F, Lavenne E, Hainaut P.
    Acta Clin Belg; 2000 Nov 02; 55(3):176-81. PubMed ID: 10981327
    [Abstract] [Full Text] [Related]

  • 17. Danaparoid: a review of its use in thromboembolic and coagulation disorders.
    Ibbotson T, Perry CM.
    Drugs; 2002 Nov 02; 62(15):2283-314. PubMed ID: 12381232
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.
    Kleinschmidt S, Seyfert UT.
    Angiology; 1995 Jan 02; 46(1):37-44. PubMed ID: 7818155
    [Abstract] [Full Text] [Related]

  • 20. [Peri-operative anticoagulation with danaparoid for a patient with Budd-Chiari syndrome and heparin-induced thrombocytopenia].
    Brémaud M, De Maistre E, Junke E, Guerci A, Lalot JM, Longrois D, Lecompte T, Meistelman C.
    Ann Fr Anesth Reanim; 2004 Feb 02; 23(1):50-5. PubMed ID: 14980323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.